 |
|||||
|
|||||
|
|||||
|
|||||
|
|||||
Previous Article | Next Article
The Journal of Neuroscience, July 15, 2001, 21(14):5027-5035
Chemokines and Glycoprotein120 Produce Pain Hypersensitivity by Directly Exciting Primary Nociceptive Neurons
Seog Bae Oh1, Phuong B. Tran1, Samantha E. Gillard1, Robert W. Hurley2, Donna L. Hammond2, and Richard J. Miller1 1 Department of Neurobiology, Pharmacology, and Physiology, and 2 Department of Anesthesia and Critical Care and The Committee on Neurobiology, University of Chicago, Chicago, Illinois 60637
Human immunodeficiency virus-1 (HIV-1) infection is associated with numerous effects on the nervous system, including pain and peripheral neuropathies. We now demonstrate that cultured rat dorsal root ganglion (DRG) neurons express a wide variety of chemokine receptors, including those that are thought to act as receptors for the HIV-1 coat protein glycoprotein120 (gp120). Chemokines that activate all of the known chemokine receptors increased [Ca2+]i in subsets of cultured DRG cells. Many neurons responded to multiple chemokines and also to bradykinin, ATP, and capsaicin. Immunohistochemical studies demonstrated the expression of the CXCR4 and CCR4 chemokine receptors on populations of DRG neurons that also expressed substance P and the VR1 vanilloid receptor. RT-PCR analysis confirmed the expression of CXCR4, CX3CR1, CCR4, and CCR5 mRNAs in DRG neurons. Chemokines and gp120 produced excitatory effects on DRG neurons and also stimulated the release of substance P. Chemokines and gp120 also produced allodynia after injection into the rat paw. Thus these results provide evidence that chemokines and gp120 may produce painful effects via direct actions on chemokine receptors expressed by nociceptive neurons. Chemokine receptor antagonists may be important therapeutic interventions in the pain that is associated with HIV-1 infection and inflammation.
Key words: neuropathies; AIDS; pain; dorsal root ganglia; G-protein-coupled receptor; substance P
Copyright © 2001 Society for Neuroscience 0270-6474/01/21145027-09$05.00/0
This article has been cited by other articles:
E. Giannini, R. Lattanzi, A. Nicotra, A. F. Campese, P. Grazioli, I. Screpanti, G. Balboni, S. Salvadori, P. Sacerdote, and L. Negri
The chemokine Bv8/prokineticin 2 is up-regulated in inflammatory granulocytes and modulates inflammatory pain
PNAS, August 25, 2009; 106(34): 14646 - 14651.
[Abstract] [Full Text] [PDF]
Y. H. Kim, C.-K. Park, S. K. Back, C. J. Lee, S. J. Hwang, Y. C. Bae, H. S. Na, J. S. Kim, S. J. Jung, and S. B. Oh
Membrane-Delimited Coupling of TRPV1 and mGluR5 on Presynaptic Terminals of Nociceptive Neurons
J. Neurosci., August 12, 2009; 29(32): 10000 - 10009.
[Abstract] [Full Text] [PDF]
F. A. White, P. Feldman, and R. J. Miller
Chemokine Signaling and the Management of Neuropathic Pain
Mol. Interv., August 1, 2009; 9(4): 188 - 195.
[Abstract] [Full Text] [PDF]
H. Jung, S. Bhangoo, G. Banisadr, C. Freitag, D. Ren, F. A. White, and R. J. Miller
Visualization of Chemokine Receptor Activation in Transgenic Mice Reveals Peripheral Activation of CCR2 Receptors in States of Neuropathic Pain
J. Neurosci., June 24, 2009; 29(25): 8051 - 8062.
[Abstract] [Full Text] [PDF]
V. Musante, F. Longordo, E. Neri, M. Pedrazzi, F. Kalfas, P. Severi, M. Raiteri, and A. Pittaluga
RANTES Modulates the Release of Glutamate in Human Neocortex
J. Neurosci., November 19, 2008; 28(47): 12231 - 12240.
[Abstract] [Full Text] [PDF]
R. J. Miller, W. Rostene, E. Apartis, G. Banisadr, K. Biber, E. D. Milligan, F. A. White, and J. Zhang
Chemokine Action in the Nervous System
J. Neurosci., November 12, 2008; 28(46): 11792 - 11795.
[Full Text] [PDF]
F. A. White, H. Jung, and R. J. Miller
Chemokines and the pathophysiology of neuropathic pain
PNAS, December 18, 2007; 104(51): 20151 - 20158.
[Abstract] [Full Text] [PDF]
C. C. Reyes-Gibby, M. Spitz, X. Wu, K. Merriman, C. Etzel, E. Bruera, R. Kurzrock, and S. Shete
Cytokine Genes and Pain Severity in Lung Cancer: Exploring the Influence of TNF-{alpha}-308 G/A IL6-174G/C and IL8-251T/A
Cancer Epidemiol. Biomarkers Prev., December 1, 2007; 16(12): 2745 - 2751.
[Abstract] [Full Text] [PDF]
V. C. J. Wallace, J. Blackbeard, A. R. Segerdahl, F. Hasnie, T. Pheby, S. B. McMahon, and A. S. C. Rice
Characterization of rodent models of HIV-gp120 and anti-retroviral-associated neuropathic pain
Brain, October 1, 2007; 130(10): 2688 - 2702.
[Abstract] [Full Text] [PDF]
I. A. Khasabova, C. L. Stucky, C. Harding-Rose, L. Eikmeier, A. J. Beitz, L. G. Coicou, A. E. Hanson, D. A. Simone, and V. S. Seybold
Chemical Interactions between Fibrosarcoma Cancer Cells and Sensory Neurons Contribute to Cancer Pain
J. Neurosci., September 19, 2007; 27(38): 10289 - 10298.
[Abstract] [Full Text] [PDF]
M. A. Thacker, A. K. Clark, F. Marchand, and S. B. McMahon
Pathophysiology of Peripheral Neuropathic Pain: Immune Cells and Molecules
Anesth. Analg., September 1, 2007; 105(3): 838 - 847.
[Abstract] [Full Text] [PDF]
H. L. Rittner, D. Labuz, M. Schaefer, S. A. Mousa, S. Schulz, M. Schafer, C. Stein, and A. Brack
Pain control by CXCR2 ligands through Ca2+-regulated release of opioid peptides from polymorphonuclear cells
FASEB J, December 1, 2006; 20(14): 2627 - 2629.
[Abstract] [Full Text] [PDF]
J. H. Sun, B. Yang, D. F. Donnelly, C. Ma, and R. H. LaMotte
MCP-1 Enhances Excitability of Nociceptive Neurons in Chronically Compressed Dorsal Root Ganglia
J Neurophysiol, November 1, 2006; 96(5): 2189 - 2199.
[Abstract] [Full Text] [PDF]
H. L. Rittner, S. A. Mousa, D. Labuz, K. Beschmann, M. Schafer, C. Stein, and A. Brack
Selective local PMN recruitment by CXCL1 or CXCL2/3 injection does not cause inflammatory pain
J. Leukoc. Biol., May 1, 2006; 79(5): 1022 - 1032.
[Abstract] [Full Text] [PDF]
G. Melli, S. C. Keswani, A. Fischer, W. Chen, and A. Hoke
Spatially distinct and functionally independent mechanisms of axonal degeneration in a model of HIV-associated sensory neuropathy
Brain, May 1, 2006; 129(5): 1330 - 1338.
[Abstract] [Full Text] [PDF]
N. Zhang and J. J. Oppenheim
Crosstalk between chemokines and neuronal receptors bridges immune and nervous systems
J. Leukoc. Biol., December 1, 2005; 78(6): 1210 - 1214.
[Abstract] [Full Text] [PDF]
H. L. Rittner, H. Machelska, and C. Stein
Leukocytes in the regulation of pain and analgesia
J. Leukoc. Biol., December 1, 2005; 78(6): 1215 - 1222.
[Abstract] [Full Text] [PDF]
F. A. White, J. Sun, S. M. Waters, C. Ma, D. Ren, M. Ripsch, J. Steflik, D. N. Cortright, R. H. LaMotte, and R. J. Miller
Excitatory monocyte chemoattractant protein-1 signaling is up-regulated in sensory neurons after chronic compression of the dorsal root ganglion
PNAS, September 27, 2005; 102(39): 14092 - 14097.
[Abstract] [Full Text] [PDF]
A. Belmadani, P. B. Tran, D. Ren, S. Assimacopoulos, E. A. Grove, and R. J. Miller
The Chemokine Stromal Cell-Derived Factor-1 Regulates the Migration of Sensory Neuron Progenitors
J. Neurosci., April 20, 2005; 25(16): 3995 - 4003.
[Abstract] [Full Text] [PDF]
N. Zhang, S. Inan, A. Cowan, R. Sun, J. M. Wang, T. J. Rogers, M. Caterina, and J. J. Oppenheim
A proinflammatory chemokine, CCL3, sensitizes the heat- and capsaicin-gated ion channel TRPV1
PNAS, March 22, 2005; 102(12): 4536 - 4541.
[Abstract] [Full Text] [PDF]
R.-R. Ji and G. Strichartz
Cell Signaling and the Genesis of Neuropathic Pain
Sci. Signal., September 28, 2004; 2004(252): re14 - re14.
[Abstract] [Full Text] [PDF]
P. T. Toth, D. Ren, and R. J. Miller
Regulation of CXCR4 Receptor Dimerization by the Chemokine SDF-1{alpha} and the HIV-1 Coat Protein gp120: A Fluorescence Resonance Energy Transfer (FRET) Study
J. Pharmacol. Exp. Ther., July 1, 2004; 310(1): 8 - 17.
[Abstract] [Full Text] [PDF]
N. Zhang, T. J. Rogers, M. Caterina, and J. J. Oppenheim
Proinflammatory Chemokines, Such as C-C Chemokine Ligand 3, Desensitize {micro}-Opioid Receptors on Dorsal Root Ganglia Neurons
J. Immunol., July 1, 2004; 173(1): 594 - 599.
[Abstract] [Full Text] [PDF]
Y.-H. Jin, T. W. Bailey, B.-y. Li, J. H. Schild, and M. C. Andresen
Purinergic and Vanilloid Receptor Activation Releases Glutamate from Separate Cranial Afferent Terminals in Nucleus Tractus Solitarius
J. Neurosci., May 19, 2004; 24(20): 4709 - 4717.
[Abstract] [Full Text] [PDF]
S B McMahon
Sensitisation of gastrointestinal tract afferents
Gut, March 1, 2004; 53(90002): ii13 - 15.
[Abstract] [Full Text] [PDF]
L. M. Haynes, L. P. Jones, A. Barskey, L. J. Anderson, and R. A. Tripp
Enhanced Disease and Pulmonary Eosinophilia Associated with Formalin-Inactivated Respiratory Syncytial Virus Vaccination Are Linked to G Glycoprotein CX3C-CX3CR1 Interaction and Expression of Substance P
J. Virol., September 15, 2003; 77(18): 9831 - 9844.
[Abstract] [Full Text] [PDF]
C. Abbadie, J. A. Lindia, A. M. Cumiskey, L. B. Peterson, J. S. Mudgett, E. K. Bayne, J. A. DeMartino, D. E. MacIntyre, and M. J. Forrest
Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2
PNAS, June 24, 2003; 100(13): 7947 - 7952.
[Abstract] [Full Text] [PDF]
R. A. Tripp, A. Dakhama, L. P. Jones, A. Barskey, E. W. Gelfand, and L. J. Anderson
The G Glycoprotein of Respiratory Syncytial Virus Depresses Respiratory Rates through the CX3C Motif and Substance P
J. Virol., June 1, 2003; 77(11): 6580 - 6584.
[Abstract] [Full Text] [PDF]
M. Lu, E. A. Grove, and R. J. Miller
Abnormal development of the hippocampal dentate gyrus in mice lacking the CXCR4 chemokine receptor
PNAS, May 14, 2002; 99(10): 7090 - 7095.
[Abstract] [Full Text] [PDF]
|
|
|
|
 |
|